Chapter 30: Cancer References


Anderson CR, Ogilvie GK, LaRue SM, et al. Effect of fish oil and arginine on acute effects of radiation injury in dogs with nasal tumors: A double-blind, randomized study (abstract). Veterinary Cancer Society/American College of Veterinary Radiology Meeting, Chicago, IL, December 1997.

Barbul A. Arginine: Biochemistry, physiology, and therapeutic implications. Journal of Parenteral and Enteral Nutrition 1986; 10: 227-238.

Beck SA, Smith KL, Tisdale MJ. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Research 1991; 51: 6089-6093.

Begin ME, Das UN, Ellis G, et al. Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins and Leukotrienes in Medicine 1985; 19: 177-182.

Begin ME, Ellis G, Das UN, et al. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. Journal of the National Cancer Institute 1986; 77: 2053-2057.

Bertone ER, Snyder LA, Moore AS. Environmental and lifestyle risk factors for oral squamous cell carcinoma in domestic cats. Journal of Veterinary Internal Medicine 2003; 17: 557-562.

Bertone ER, Snyder LA, Moore AS. Environmental tobacco smoke and risk of malignant lymphoma in pet cats. American Journal of Epidemiology 2002; 156: 268-273.

Birnbaum MJ, Haspel HC, Rosen OM. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. Science 1987; 235: 1495-1498.

Bonnet BN, Egenvall A, Hedhammar A, et al. Mortality in over 350,000 insured Swedish dogs from 1995-2000: I. Breed-, gender-, age- and cause-specific rates. Acta Veterinaria Scandinavica 2005; 46(3): 105-120.

Bozzetti F, Pagnoni AM, Del Vecchio M. Excessive caloric expenditure as a cause of malnutrition in patients with cancer. Surgery Gynecology and Obstetrics 1980; 150: 229-234.

Bray GA, Campfield LA. Metabolic factors in the control of energy stores. Metabolism 1975; 24: 99-117.

Bronson RT. Variation in age at death of dogs of different sexes and breeds. American Journal of Veterinary Research 1982; 43: 2057-2059.

Bukowski JA, Wartenberg D, Goldschmidt M. Environmental causes for sinonasal cancers in pet dogs, and their usefulness as sentinels of indoor cancer risk. Journal of Toxicology and Environmental Health 1998; 54: 579-591.

Burke D, Alverdy JC, Aoys E, et al. Glutamine-supplemented total parenteral nutrition improves gut immune function. Archives of Surgery 1989; 124: 1396-1400.

Buzby GP, Steinberg JJ. Nutrition in cancer patients. Symposium on Surgical Nutrition 1981; 61: 691-699.

Canine Cancer (monograph). Hill’s Pet Nutrition, Inc, Topeka, KS, 1998.

Chang WL, Chapkin RS, Lupton JR. Fish oil blocks azoxymethane-induced rat colon tumorigenesis by increasing cell differentiation and apoptosis rather than decreasing cell proliferation. Journal of Nutrition 1998; 128: 491-497.

Chesney J. 6-Phosphofructo-2-kinase/fructose-2,6-bisphophatase and tumor cell glycolysis. Current Opinion in Clinical Nutrition and Metabolic Care 2006; 9: 535-539.

Chlebowski RT, Heber D. Metabolic abnormalities in cancer patients: Carbohydrate metabolism. Surgical Clinics of North America 1986; 66: 957-968.

Chlebowski RT, Herrold J, Ali I, et al. Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer. Cancer 1986; 58: 183-186.

Chlebowski RT. Nutritional support of the medical oncology patient. Hematology/Oncology Clinics of North America 1991; 5: 147-160.

Chory ET, Mullen JL. Nutritional support of the cancer patient: Delivery systems and formulations. Surgical Clinics of North America 1986; 66: 1105-1120.

Correa SS, Mauldin GN, Mauldin GE, et al. Serum alpha 1-acid glycoprotein concentrations in cats with lymphoma. Journal of the American Animal Hospital Association 2001; 37: 153-158.

Daly JM, Lieberman M, Goldfine J, et al. Enteral nutrition with supplemental arginine, RNA and omega-3 fatty acids: A prospective clinical trial (abstract). Journal of Parenteral and Enteral Nutrition 1991; 15: 19S.

Delarue J, Lerebours E, Tilly H, et al. Effect of chemotherapy on resting energy expenditure in patients with non-Hodgkin’s lymphoma. Cancer 1990; 65: 2455-2459.

Dempsey DT, Feurer ID, Knox LS, et al. Energy expenditure in malnourished GI cancer patients. Cancer 1984; 53: 1265-1273.

Dempsey DT, Knox LS, Mullen JL, et al. Energy expenditure in malnourished patients with colorectal cancer. Archives of Surgery 1986; 121: 789-795.

Dempsey DT, Mullen JL. Macronutrient requirements in the malnourished cancer patient. Cancer 1985; 55: 290-294.

Dewys WD. Pathophysiology of cancer cachexia: Current understanding and areas of future research. Cancer Research 1982; 42: 722-726.

Dippenaar N, Booyenes J. The reversibility of cancer: Evidence that malignancy in melanoma cells is gamma linolenic acid deficiency dependent. South African Medical Journal 1982; 62: 505-507.

Egenvall A, Bonnet BN, Hedhammar A, et al. Mortality in over 350,000 insured Swedish dogs from 1995-2000: II. Breed-specific age and survival patterns and relative risk for causes of death. Acta Veterinaria Scandinavica 2005; 46(3): 121-136.

Fascetti AJ, Mauldin GE, Mauldin GN. Correlation between serum creatine kinase activities and anorexia in cats. Journal of Veterinary Internal Medicine 1997; 11(1): 9-13.

Fearon KC, Voss AC, Hustead DS; Cancer Cachexia Study Group. Definition of cancer cachexia: Effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. American Journal of Clinical Nutrition 2006; 83(6): 1345-1350.

Flier JS, Mueckler MM, Usher P, et al. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 1987; 235: 1492-1495.

Fredrix EWHM, Wouters EFM, Soeters PB, et al. Resting energy expenditure in patients with non-small cell lung cancer. Cancer 1991; 68: 1616-1621.

Friedrich O. Critical illness myopathy: What is happening? Current Opinion in Clinical Nutrition and Metabolic Care 2006; 9: 403-409.

Glickman LT, Schofer FS, McKee LJ, et al. Journal of Toxicology and Environmental Health 1989; 28: 407-414.

Hahn KA, Freeman KP, Barnhill MA, et al. Serum 1-acid glycoprotein concentration in cats with lymphoma. Journal of the American Veterinary Medical Association 1999; 214: 1023-1025.

Hansell DT, Davies JWL, Burns HJG. The relationship between resting energy expenditure and weight loss in benign and malignant disease. Annals of Surgery 1986; 203: 240-243.

Heber D, Byerley LO, Chi J, et al. Pathophysiology of malnutrition in the adult cancer patient. Cancer 1986; 58: 1867-1873.

Holian O, Nelson R. Action of long-chain fatty acids on protein kinase C activity: Comparison of omega-6 and omega-3 fatty acids. Anticancer Research 1992; 12: 975-980.

Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA. A Cancer Journal for Clinicians 2007; 57: 43-66.

Jenski LJ, Sturdevant LK, Ehringer WD, et al. Omega-3 fatty acid modification of membrane structure and function. I. Dietary manipulation of tumor cell susceptibility to cell and complement mediated lysis. Nutrition and Cancer 1993; 19: 135-146.

Jho DH, Babcock TA, Tevar R, et al. Eicosapentaenoic acid supplementation reduces tumor volume and attenuates cachexia in a rat model of progressive non-metastasizing malignancy. Journal of Parenteral and Enteral Nutrition 2002; 26(5): 291-297.

Kardinal CG, Loprinzi CL, Schaid DJ, et al. A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia. Proceedings of the American Society of Clinical Oncology 1990; 9: 325.

Kazmierski KJ, Ogilvie GK, Fettman MJ, et al. Serum zinc, chromium, and iron concentrations in dogs with lymphoma and osteosarcoma. Journal of Veterinary Internal Medicine 2001; 15: 585-588.

Kokal WA. The impact of antitumor therapy on nutrition. Cancer 1985; 55: 273-278.

Kurzer M, Meguid MM. Cancer and protein metabolism. Surgical Clinics of North America 1986; 66: 969-1001.

Landel AM, Hammond WG, Mequid MM. Aspects of amino acid and protein metabolism in cancer-bearing states. Cancer 1985; 55: 230-237.

Langstein HN, Norton JA. Mechanisms of cancer cachexia. Hematology/Oncology Clinics of North America 1991; 5: 103-123.

Lawson DH, Richmond A, Nixon DW, et al. Metabolic approaches to cancer cachexia. Annual Review of Nutrition 1982; 2: 277-301.

Lingass F, Comstock KE, Kirkness EF, et al. A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German shepherd dog. Human Molecular Genetics 2003; 12(23): 3043-3053.

London CA, Vail DM. Tumor biology. In: Withrow SJ, MacEwen EG, eds. Small Animal Clinical Veterinary Oncology. Philadelphia, PA: WB Saunders Co, 1996; 16-31.

Lowell JA, Parnes HL, Blackburn GL. Dietary immunomodulation: Beneficial effects on carcinogenesis and tumor growth. Critical Care Medicine 1990; 18: S145-S148.

Macy DW. Hematopoietic tumors. In: Withrow SJ, MacEwen EG, eds. Small Animal Clinical Oncology. Philadelphia, PA: WB Saunders Co, 1996; 432-451.

Mazzaferro EM, Hackett TB, Stein TP, et al. Metabolic alterations in dogs with osteosarcoma. American Journal of Veterinary Research 2001; 62(8): 1234-1239.

McAndrew PF. Fat metabolism and cancer. Surgical Clinics of North America 1986; 66: 1003-1012.

McGeer AJ, Detsky AS, O’Rourke K. Parenteral nutrition in cancer patients undergoing chemotherapy: A meta-analysis. Nutrition 1990; 6: 478-483.

Mechanick J. Metabolic mechanisms of stress hyperglycemia. Journal of Parenteral and Enteral Nutrition 2006; 30: 157-163.

Mechanick JI, Brett EM. Nutrition and the chronically critically ill patient. Current Opinion in Clinical Nutrition and Metabolic Care 2005; 8: 33-39.

Menendez JA, Lupu R. Oncogenic properties of endogenous fatty acid metabolism: Molecular pathology of fatty acid synthase in cancer cells. Current Opinion in Clinical Nutrition and Metabolic Care 2006; 9: 346-357.

Mengeaud V, Nano JL, Fournel S, et al. Effects of eicosapentaenoic acid, gamma-linolenic acid and prostaglandin E1 on three human colon carcinoma cell lines. Prostaglandins, Leukotrienes and Essential Fatty Acids 1992; 47: 313-319.

Michel KE, Sorenmo K, Shofer FS. Evaluation of body condition and weight loss in dogs presented to a veterinary oncology service. Journal of Veterinary Internal Medicine 2004; 18(5): 692-695.

Millanta F, Silvestri G, Vaselli C, et al. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: A preliminary study of autocrine and paracrine loops. Research in Veterinary Science 2006; 81(3): 350-357.

Modiano JF, Breen M, Burnett RC, et al. Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk. Cancer Research 2005; 65(13): 5654-5661.

Moore GE, Burkman KD, Carter MN, et al. Causes of death or reasons for euthanasia in military working dogs: 927 cases (1993-1996). Journal of the American Veterinary Medical Association 2001; 219(2): 209-214.

Northrup NC, Selting KA, Rassnick KM, et al. Outcomes of cats with oral tumors treated with mandibulectomy: 42 cases. Journal of the American Animal Hospital Association 2006, 42(5): 350-360.

NRC. (National Research Council). Nutrient Requirements of Dogs and Cats. Washington, DC: National Academies Press, 2006.

Ogilvie GK, Fettman MJ, Mallinckrodt CH, et al. Effect of fish oil, arginine and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: A double-blind, randomized study placebo-controlled study. Cancer 2000; 88(8): 1916-1928.

Ogilvie GK, Ford RD, Vail DM, et al. Alterations in lipoprotein profiles in dogs with lymphoma. Journal of Veterinary Internal Medicine 1994; 8: 62-66.

Ogilvie GK, Moore AS. Nutritional management. In: Managing the Veterinary Cancer Patient: A Practice Manual. Trenton, NJ: Veterinary Learning Systems, 1995a; 44-96.

Ogilvie GK, Moore AS. Nutritional support. In: Managing the Veterinary Cancer Patient: A Practice Manual. Trenton, NJ: Veterinary Learning Systems, 1995; 124-127.

Ogilvie GK, Vail DM, Wheeler SJ. Effect of chemotherapy and remission on carbohydrate metabolism in dogs with lymphoma. Cancer 1992; 69: 233-238.

Ogilvie GK, Vail DM. Advances in nutritional therapy for the cancer patient. Veterinary Clinics of North America: Small Animal Practice 1990; 20: 969-985.

Ogilvie GK, Vail DM. Metabolic alterations and nutritional therapy for the veterinary cancer patient. In: Withrow SJ, MacEwen EG, eds. Small Animal Clinical Veterinary Oncology. Philadelphia, PA: WB Saunders Co, 1996; 117-128.

Ogilvie GK, Vail DM. Unique metabolic alterations associated with cancer cachexia in the dog. In: Kirk RW, Bonagura JD, eds. Current Veterinary Therapy XI. Philadelphia, PA: WB Saunders Co, 1992; 433-438.

Ogilvie GK, Walters LM, Salman MD, et al. Alterations in carbohydrate metabolism in dogs with non-hematopoietic malignancies, American Journal of Veterinary Research 1997; 58: 277-281.

Ogilvie GK, Walters LM, Salman MD, et al. Effect of anesthesia and surgery on energy expenditure determined by indirect calorimetry in dogs with malignant and non-malignant conditions. Journal of the American Veterinary Medical Association 1996; 57: 1463-1467.

Oram-Smith JC, Stein TP. Intravenous nutrition and tumor host protein metabolism. Journal of Surgical Research 1977; 22: 499-503.

Pascale AW, Ehringer WD, Stillwell W, et al. Omega-3 fatty acid modification of membrane structure and function. II. Alteration by docosahexaenoic acid of tumor cell sensitivity to immune cytolysis. Nutrition and Cancer 1993; 19: 147-157.

Perez-Alenza D, Rutteman GR, Pena L, et al. Relationship between habitual diet and canine mammary tumors in a case-control study. Journal of Veterinary Internal Medicine 1998; 12: 132-139.

Perez-Alenza MD, Jiménez A, Nieto AI, et al. First description of feline inflammatory mammary carcinoma: Clinicopathological and immunohistochemical characteristics of three cases. Breast Cancer Research 2004; 6(4): R300-R307.

Phipps BE, Saker KE, Huckle WR, et al. Effect of docosahaexanoic and linoleic acids on the proliferation of epidermal growth factor receptor-positive and -negative breast tumor cell lines. From: Phipps BE. Polyunsaturated fatty acids and epidermal growth factor receptor/mitogen-activated protein kinase signal transduction cascade in mammary cancer. PhD Dissertation, Virginia Polytechnic Institute and State University, Blacksburg, 2004.

Plumb JA, Luo W, Kerr DJ. Effect of polyunsaturated fatty acids on the drug sensitivity of human tumor cell lines resistant to either cisplatin or doxorubicin. British Journal of Cancer 1993; 67: 728-733.

Pomposelli JJ, Flores EA, Blackburn GL, et al. Diets enriched with n-3 fatty acids ameliorate lactic acidosis by improving endotoxin-induced tissue hypoperfusion in guinea pigs. Annals of Surgery 1989; 213: 166-176.

Premachandra BN, Perlstein IB, Williams K. Circulating and tissue thyroid hormones in relation to hormone action: Pathophysiologic significance. In: Fatherby K, Palde Druyter SB, eds. Hormones in Normal and Abnormal Human Tissues, vol 2. Berlin: 1981; 282-287.

Proschowsky HF, Rugbjerg H, Ersboll AK. Mortality of purebred and mixed-breed dogs in Denmark. Preventive Veterinary Medicine 2003; 58(1-2): 63-74.

Raghavan M, Knapp DW, Bonney PL, et al. Evaluation of the effect of dietary vegetable consumption on reducing the risk of transitional cell carcinoma of the urinary bladder in Scottish terriers. Journal of the American Veterinary Medical Association 2005; 227(1): 94-100.

Ramesh G, Das UN, Koratkar R, et al. Effect of essential fatty acids on tumor cells. Nutrition 1992; 8: 343-347.

Reif JS, Bruns C, Lower KS. Cancer of the nasal cavity and paranasal sinuses and exposure to environmental tobacco smoke in pet dogs. American Journal of Epidemiology 1998; 147: 488-492.

Ristow M. Oxidative metabolism in cancer growth. Current Opinion in Clinical Nutrition and Metabolic Care 2006; 9: 339-345.

Ross BT. The impact of radiation therapy on the nutrition status on the cancer patient: An overview. In: Bloch AS, ed. Nutrition Management of the Cancer Patient. Rockville, MD: Aspen Publishers, 1990; 173-180.

Roush GC, Pero RW, Powell J, et al. Modulation of the cancer susceptibility measure, adenosine diphosphate ribosyl transferase (ADPRT), by differences in n-3 and n-6 fatty acids. Nutrition and Cancer 1991; 16: 197-207.

Saker KE, Cowing BE, Herbein JH. Influence of PUFA on a prospective cancer biomarker in feline adipose. Proceedings of the 6th International Symposium on Predictive Oncology and Intervention Strategies 2002; 300: 133.

Saker KE, Cowing BE, Huckle WR, et al. Influence of PUFA on immune cell MAPK: A prospective cancer biomarker. Proceedings of the 6th International Symposium on Predictive Oncology and Intervention Strategies 2002a; 263: 123.

Saker KE, Phipps BE, Huckle WR, et al. Concentration of PUFA can influence EGFR/MAPK signal transduction in human breast cancer cells. Proceedings for the 7th International Symposium on Predictive Oncology and Intervention Strategies 2004; S-79.

Sanders LM, Henderson CE, Hong MY, et al. An increase in reactive oxygen species by dietary fish oil coupled with the attenuation of antioxidant defenses by dietary pectin enhances rat colonocyte apoptosis. Journal of Nutrition 2004; 134(12): 3233-3238.

Sandow PL, Hejrat-Yazdi M, Heft MW. Taste loss and recovery following radiation therapy. Journal of Dental Research 2006; 85(7): 608-611.

Segev G, Klement E, Aroch I. Toxic neutrophils in cats: Clinical and clinicopathologic features, and disease prevalence and outcomea retrospective case control study. Journal of Veterinary Internal Medicine 2006; 20(1): 20-31.

Selting KA, Ogilvie GK, Gustafson DL, et al. Evaluation of the effects of dietary n-3 fatty acid supplementation on the pharmacokinetics of doxorubicin in dogs with lymphoma. American Journal of Veterinary Research 2006; 67(1): 145-151.

Selting KA, Ogilvie GK, Lana SE, et al. Serum alpha 1-acid glycoprotein concentrations in healthy and tumor-bearing cats. Journal of Veterinary Internal Medicine 2000; 14: 503-506.

Sestoft L. Metabolic aspects of the calorigenic effect of thyroid hormone in mammals. Clinical Endocrinology 1980; 13: 489-506.

Shein PS, Kisner D, Haller D, et al. Cachexia of malignancy. Cancer 1976; 43: 2070-2076.

Shein PS, Kisner D, Haller D, et al. The oxidation of body fuel stores in cancer patients. Annals of Surgery 1986; 204: 637-642.

Sheng-Long YE, Istafan NW, Driscoll DF, et al. Tumor and host response to arginine and branched chain amino acid enriched total parenteral nutrition. Cancer 1992; 69: 261-270.

Siroen MPC, van Bokhorst-de van der Schueren MAE, Richir MC, et al. The prognostic value of severe malnutrition in the development of nonthyroidal illness in head and neck cancer patients. Journal of Parenteral and Enteral Nutrition 2006; 30(5): 415-420.

Snyder LA, Bertone ER, Jakowski RM, et al. p53 expression and environmental tobacco smoke exposure in feline oral squamous cell carcinoma. Veterinary Pathology 2004; 41: 209-214.

Sonnenschein EG, Glickman LT, Goldschmidt MH, et al. Body conformation, diet, and risk of breast cancer in pet dogs: A case-control study. American Epidemiology 1991; 133: 694-703.

Swinnen JV, Brusselmans K, Verhoeven G. Increased lipogenesis in cancer cells: New players, novel targets. Current Opinion in Clinical Nutrition and Metabolic Care 2006; 9: 358-365.

Tachibana K, Mukai K, Hirauka I, et al. Evaluation of the effect of arginine enriched amino acid solution on tumor growth. Journal of Parenteral and Enteral Nutrition 1985; 9: 428-434.

Teyek JA, Bistrian BR, Hehir DJ, et al. Improved protein kinetics and albumin synthesis by branched chain amino acid-enriched total parenteral nutrition in cancer cachexia. Cancer 1986; 58: 147-157.

Theologides A. Cancer cachexia. Cancer 1979; 43: 2004-2012.

Tisdale MJ, Brennan RA, Fearon KC. Reduction of weight loss and tumour size in a cachexia model by a high fat diet. British Journal of Cancer 1987; 56: 39-43.

Vail DM, Ogilvie GK, Fettman MJ, et al. Exacerbation of hyperlactatemia by infusion of lactated Ringer’s solution in dogs with lymphoma. Journal of Veterinary Internal Medicine 1990b; 4: 228-232.

Vail DM, Ogilvie GK, Wheeler SL, et al. Alterations in carbohydrate metabolism in canine lymphoma. Journal of Veterinary Internal Medicine 1990a; 4: 8-11.

Vail DM, Ogilvie GK, Wheeler SL. Metabolic alterations in patients with cancer cachexia. Compendium on Continuing Education for the Practicing Veterinarian 1990; 12: 381-387.

Vail DM, Panciera D, Ogilvie GK. Thyroid hormone concentrations in conditions of chronic weight loss in dogs with special reference to cancer cachexia. Journal of Veterinary Internal Medicine 1994; 8: 122-127.

Walters LM, Ogilvie GK, Fettman MJ, et al. Repeatability of energy expenditure measurements in normal dogs by indirect calorimetry. American Journal of Veterinary Research 1993; 54: 1881-1885.

Weeth LP, Fascetti AJ, Kass PH, et al. Prevalence of obese dogs in a population of dogs with cancer. American Journal of Veterinary Research 2007; 68(4): 389-398.

Willcox JC, Cou J, Shaw J, et al. Prednisolone as an appetite stimulant in patients with cancer. British Medical Journal 1984; 288: 27-31.

Wurth U. Introduction to acupuncture. Holistic Medicine Proceedings 351. Indooroopilly QLD Australia, August 2003: 257-292.

Zyliez Z, Schwantje O, Wagener DJT, et al. Metabolic response to enteral food in different phases of cancer cachexia in rats. Oncology 1990; 47: 87-91.



Box 30-1 Bibliography

Beck SA, Smith KL, Tisdale MJ. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Research 1991; 51: 6089-6093.

Cowing BE, Saker KE. Polyunsaturated fatty acids and EGFRMAPK signaling in mammary cancer. Journal of Nutrition 2001; 131: 1125-1128.

Degner SC, Kemp MQ, Bowden GT, et al. Conjugated linoleic acid attenuates cyclooxygenase-2 transcriptional activity via an anti-AP-1 mechanism in MCF-7 breast cancer cells. Journal of Nutrition 2006; 136(2): 421-427.

Gelin J, Moldawer LL, Lonnroth C, et al. Role of endogenous tumor necrosis factor- and interleukin-1 for experimental tumor growth and the development of cancer cachexia. Cancer Research 1991; 51: 415-421.

Goncalves CG, Ramos EJB, Suzuki S, et al. Omega-3 fatty acids and anorexia. Current Opinion in Clinical Nutrition and Metabolic Care 2005; 8: 403-407.

Kumar GS, Das UN, Kumar KV, et al. Effect of n-6 and n-3 fatty acids on the proliferation of human lymphocytes and their secretion of TNF- and IL-2 in vitro. Nutrition Research 1992; 12: 815-823.

Lee S, Gura KM, Kim S, et al. Current clinical applications of omega-6 and omega-3 fatty acids. Nutrition in Clinical Practice 2006; 21(4): 323-341.

Lorincz AMS, Sukumar S. Molecular links between obesity and breast cancer. Endocrine-Related Cancer 2006; 13: 279-292.

Pomposelli JJ, Flores EA, Blackburn GL, et al. Diets enriched with n-3 fatty acids ameliorate lactic acidosis by improving endotoxin-induced tissue hypoperfusion in guinea pigs. Annals of Surgery 1989; 213: 166-176.

Tevar BS, Jho DH, Babcock T, et al. Omega-3 fatty acid supplementation reduces tumor growth and vascular endothelial growth factor expression in a model of progressive non-metastasizing malignancy. Journal of Parenteral and Enteral Nutrition 2002; 26(5): 285-289.



Box 30-2 Bibliography

Alverdy JC. Effects of glutamine-supplemented diets on immunology of the gut. Journal of Parenteral and Enteral Nutrition 1990; 14: 109S-113S.

Asselin BL, Ryan D, Frantz CN, et al. In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase. Cancer Research 1989; 49: 4363-4369.

Bianchi G, Marzocchi R, Agostini F, et al. Update on nutritional supplementation with branched-chain amino acids. Current Opinion in Clinical Nutrition and Metabolic Care 2005; 8: 83-87.

Cangiano C, Laviano A, Meguid MM, et al. Effects of administration of oral branched-chain amino acids on anorexia and caloric intake in cancer patients. Journal of the National Cancer Institute 1996; 88: 550-552.

Gomes-Marcondes MC, Ventrucci G, Toledo MT, et al. A leucine-supplemented diet improved protein content of skeletal muscle in young tumor-bearing rats. Brazilian Journal of Medical and Biological Research 2003; 36: 1589-1594.

Heyman SN, Rosen S, Silva P, et al. Protective action of glycine in cisplatin nephrotoxicity. Kidney International 1991; 40: 273-279.

Laviano A, Muscaritoli M, Cascino A, et al. Branched-chain amino acid: The best compromise to achieve anabolism? Current Opinion in Clinical Nutrition and Metabolic Care 2005; 8: 408-414.

Marks SL, Cook AK, Reader R, et al. Glutamine supplementation of an amino acid-based purified diet fails to improve intestinal mucosal integrity following methotrexate-induced enteritis in cats. From: Marks SL. Dietary modulation of methotrexate-induced enteritis in cats. PhD Dissertation, University of California, Davis, 1996.

Meadows GG, Oeser DE. Response by B16 melanoma-bearing mice to varying levels of phenylalanine and tyrosine. Nutrition Report International 1983; 28: 1073-1088.

Meadows GG, Pierson HF, Abdallah RM, et al. Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa levodopa methyl ester chemotherapy. Cancer Research 1982; 42: 3056-3065.

Paddon-Jones D, Sheffield-Moore M, Urban RJ, et al. Essential amino acid and carbohydrate supplementation ameliorates muscle protein loss in humans during 28 days bedrest. Journal of Clinical Endocrinology & Metabolism 2004; 89: 4351-4358.

Poon RT, Yu WC, Fan ST, et al. Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: A randomized trial. Alimentary Pharmacology and Therapeutics 2004; 19: 779-788.

Ristow M. Oxidative metabolism in cancer growth. Current Opinion in Clinical Nutrition and Metabolic Care 2006; 9: 339-345.

Sheng-Long YE, Istafan NW, Driscoll DF, et al. Tumor and host response to arginine and branched chain amino acid enriched total parenteral nutrition. Cancer 1992; 69: 261-270.

Souba WW. Glutamine and cancer. Annals of Surgery 1993; 218: 715-728.

Stern PH, Hoffman RM. Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. Journal of the National Cancer Institute 1986; 76: 629-634.

Todorva VK, Harms SA, Kaufmann Y, et al. Effect of dietary glutamine on tumor glutathione levels and apoptosis-related proteins in DMBA-induced breast cancer of rats. Breast Cancer Research and Treatment 2004; 88: 247-256.

Ventrucci G, Mello MA, Gomes-Marcondes MC. Proteosome activity is altered in muscle tissue of tumor-bearing rats fed a leucine-rich diet. Endocrine-Related Cancer 2004; 11: 887-895.

Wakshlag JJ, Kallfelz FA, Wakshlag RR, et al. The effects of branched-chain amino acids on canine neoplastic cell proliferation and death. Journal of Nutrition 2006; 136: 2007S-2010S.

Windmueller HG, Spaeth AG. Respiratory fuels and nitrogen metabolism in vivo in small intestine of fed rats. Quantitative importance of glutamine, glutamate, and aspartate. Journal of Biological Chemistry 1980; 255: 107-112.

Xu D, Lu Q, Thirstrup C, et al. Elemental diet-induced bacterial translocation and immunosuppression is not reversed by glutamine. Journal of Trauma 1993; 35: 821-824.



Box 30-3 Bibliography

Bertram JS, Kolonel LN, Meyskens FL. Rationale and strategies for chemoprevention of cancer in humans. Cancer Research 1987; 47: 3012-3018.

Boutwell RK. An overview of the role of diet and nutrition in carcinogenesis. In: Nutrition, Growth and Cancer. New York, NY: Alan R. Liss, Inc, 1988.

Branda RF. Effects of folic acid deficiency on tumor cell biology. In: Jacobs MM, ed. Vitamins and Minerals in the Prevention and Treatment of Cancer. Boca Raton, FL: CRC Press Inc, 1991; 167-185.

Chance WT, Balasubramainiam A, Sheriff S, et al. Possible role of neuropeptide Y in experimental cancer anorexia. In: Jacob MM, ed. Diet and Cancer: Markers, Prevention and Treatment. New York, NY: Plenum Press, 1993; 109-134.

Hong WK, Lipman SM, Itri LM, et al. Prevention of secondary primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. New England Journal of Medicine 1990; 323: 796-805.

Jolly CA. Diet manipulation and prevention of aging, cancer and autoimmune disease. Current Opinion in Clinical Nutrition and Metabolic Care 2005; 8: 382-387.

Kline K, Cochran GS, Sanders BG. Growth inhibitory effects of vitamin E succinate on retrovirus-transformed tumor cells in vitro. Nutrition and Cancer 1990; 14: 27-35.

Kline K, Rao A, Romach EH, et al. Vitamin E effects on retrovirus-induced immune dysfunction. Annals of the New York Academy of Science 1990; 58: 294.

Kline K, Sanders BG. Modulation of immune suppression and enhanced tumorigenesis in retrovirus tumor challenged chickens treated with vitamin E. In Vivo 1989; 3: 161-185.

Lamm DL, Riggs DR, Shriver JS, et al. Megadose vitamins in bladder cancer: A double blind clinical trial. Journal of Urology 1994; 151: 21-26.

Li J, Sartorelli CA. Synergistic induction of the differentiation of WEH1-38 D+ myelomonocytic leukemia cells by retinoic acid and granulocyte colony-stimulating factor. Leukemia Research 1992; 16: 571-577.

Micronutrients, nonnutritive dietary factors and cancer. In: Reddy BS, Cohen LA, eds. Diet, Nutrition, and Cancer: A Critical Evaluation, vol II. New York, NY: CRC Press Inc, 1986.

Mirvish SS. Effects of vitamins C and E on N-nitroso compound formation, carcinogenesis, and cancer. Cancer 1986; 58: 1842-1855.

National Academy of Sciences. Diet and Health: Implications for Reducing Chronic Disease Risk. Washington, DC: National Academy Press, 1989.

Ogilvie GK, Vail DM. Advances in nutritional therapy for the cancer patient. Veterinary Clinics of North America: Small Animal Practice 1990; 20: 969-989.

Pirisi L, Batova A, Jenkins GR, et al. Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids. Cancer Research 1992; 52: 187-192.

Quillin P. An overview of the link between nutrition and cancer. In: Quillin P, Williams RM, eds. Adjuvant Nutrition Cancer Treatment. Arlington Heights, IL: Cancer Treatment Foundation, 1993; 1-17.

Weisburg JH. Interactions of nutrients in oncogenesis. American Journal of Clinical Nutrition 1991; 53: 2265-2271.

White SD, Rosychuk RA, Scott KV, et al. Use of isotretinoin and etretinate for the treatment of benign cutaneous neoplasia and cutaneous lymphoma in dogs. Journal of the American Veterinary Medical Association 1993; 202: 387-391.



Box 30-4 Bibliography


Ip C. Factors influencing the anticarcinogenic efficacy of selenium in dimethylbenzanthracene-induced mammary tumorigenesis in rats. Cancer Research 1981; 41: 2638-2644.

Jacobs MM, Griffin AC. Effects of selenium on chemical carcinogenesis: Comparative effects on antioxidants. Biological Trace Element Research 1979; 1: 2-21.

Jacobs MM, Jansson B, Griffin AC. Inhibitory effects of selenium on 1,2-dimethylhydrazine and methylazoxymethanol acetate induction of colon tumors. Cancer Letters 1977; 2: 133-144.

Ogilvie GK, Vail DM. Metabolic alterations and nutritional therapy for the veterinary cancer patient. In: Withrow SJ, MacEwen EG, eds. Clinical Veterinary Oncology. Philadelphia, PA: WB Saunders Co, 1996.

Shamberger RJ, Rukovena E, Longfield AK, et al. Antioxidants and cancer. I. Selenium in the blood of normal and cancer patients. Journal of the National Cancer Institute 1973; 50: 867-887.

Torti FM, Torti SV. Cytokines, iron homeostasis and cancer. In: Jacobs MM, ed. Diet and Cancer: Markers, Prevention, and Treatment. New York, NY: Plenum Press, 1993; 237-245.



Box 30-5 Bibliography


Afaq F, Saleem M, Krueger CG, et al. Anthocyanin- and hydrolysable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. International Journal of Cancer 2005; 113: 423-433.

Albrecht M, Jiang W, Kumi-Diaka J, et al. Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. Journal of Medicinal Food 2004; 7: 274-283.

Billings PC, Habres JM, Kennedy AR. Inhibition of radiation-induced transformation of C3H10T1/2 cells by specific protease substrates. Carcinogenesis 1990; 11: 329-332.

Funk MA, Baker DH. Effect of soy products on methotrexate toxicity in rats. Journal of Nutrition 1991; 121: 1684-1692.

Kawaii S, Lansky EP. Differentiation-promoting activity of pomegranate (Punica granatum) fruit extracts in HL-60 human promyelocytic leukemia cells. Journal of Medicinal Food 2004; 7: 13-18.

Kennedy AR. Effects of protease inhibitors and vitamin E in the prevention of cancer. In: Prasad KN, Meyskens FL, eds. Nutrients and Cancer Prevention. Clifton, NJ: The Humana Press Inc, 1990; 79-98.

Kohno H, Suzuki R, Yasui Y, et al. Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats. Cancer Science 2004; 95: 481-486.

Marks SL, Reader R, Backus RC, et al. Dietary soybean protein helps maintain intestinal mucosal integrity in cats with methotrexate-induced enteritis. In: Marks SL. Dietary modulation of methotrexate-induced enteritis in cats. PhD Dissertation, University of California, Davis, 1996.

McAnena OJ, Harvey LP, Bonau RA, et al. Alteration of methotrexate toxicity in rats by manipulation of dietary components. Gastroenterology 1987; 92: 354-360.

Messadi DV, Billings PC, Shklar G, et al. Inhibition of oral carcinogenesis by a protease inhibitor. Journal of the National Cancer Institute 1986; 76: 447-452.

St. Clair W, Billings P, Carew J, et al. Suppression of DMH-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor. Cancer Research 1990; 50: 580-586.

Tanner AE, Saker KE, Ju Y, et al. Cell proliferation of feline and human breast cancer cell types is inhibited by pomegranate juice. Proceedings AAVN Clinical Nutrition and Research Symposium 2007; 4.

Wargovich MJ, Sumiyoshi H, Baer A, et al. Chemoprevention of GI cancer in animals by naturally occurring organo-sulfur compounds in allium vegetables. In: Jacobs MM, ed. Vitamins and Minerals in the Prevention and Treatment of Cancer. Boca Raton, FL: CRC Press Inc, 1991.

Weed H, McGandy RB, Kennedy AR. Protection against dimethylhydrazine-induced adenomatous tumors of the mouse colon by the dietary addition of an extract of soybeans containing the Bowman-Birk protease inhibitor. Carcinogenesis 1985; 6: 1239-1241.

Williams M. The role of dietary factors in cancer prevention: Beyond fruits and vegetables. Nutrition in Clinical Practice 2005; 20: 451-459.

Witschi H, Kennedy AR. Modulation of lung tumor development in mice with the soybean-derived Bowman-Birk protease inhibitor. Carcinogenesis 1989; 10: 2275-2277.